|
|
|
Volumn 137, Issue 5, 2001, Pages 649-652
|
|
A new rexinoid for cutaneous T-cell lymphoma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEXAROTENE;
CYTOKINE;
ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;
ETRETINATE;
INTERLEUKIN 1;
ISOTRETINOIN;
LIGAND;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;
RETINOIC ACID RECEPTOR;
RETINOID;
RETINOID X RECEPTOR;
REXINOID;
STEROID;
TROGLITAZONE;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ANIMAL MODEL;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
EDITORIAL;
FEMALE;
HUMAN;
HYPERLIPIDEMIA;
HYPOTHYROIDISM;
LYMPHOMA;
MAJOR CLINICAL STUDY;
MALE;
MOUSE;
MULTICENTER STUDY;
NONHUMAN;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PSORIASIS;
SKIN LYMPHOMA;
T CELL LYMPHOMA;
TREATMENT OUTCOME;
ANIMALS;
HUMANS;
LIGANDS;
LYMPHOMA, T-CELL;
RECEPTORS, RETINOIC ACID;
RETINOID X RECEPTORS;
SKIN NEOPLASMS;
TRANSCRIPTION FACTORS;
|
|
EID: 0035012314
PISSN: 0003987X
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (33)
|
|
References (34)
|
